Showing 1 to 2 of 2 results


Amgen's Unconventional AI Hire: Nike Data Scientist to Lead Drug Discovery
Amgen, a $151 billion pharmaceutical company, hired Sean Bruich, Nike's data science expert, as its senior vice president for AI and data in August 2023 to accelerate drug discovery and operational efficiency, reflecting the industry's growing reliance on AI and cross-industry talent acquisition.
Amgen's Unconventional AI Hire: Nike Data Scientist to Lead Drug Discovery
Amgen, a $151 billion pharmaceutical company, hired Sean Bruich, Nike's data science expert, as its senior vice president for AI and data in August 2023 to accelerate drug discovery and operational efficiency, reflecting the industry's growing reliance on AI and cross-industry talent acquisition.
Progress
48% Bias Score

Dow Jones Stocks Poised for Growth in 2025: Merck and Nvidia Lead the Way
Wall Street analysts predict strong gains for select Dow Jones stocks in 2025, with Merck leading at 32% projected upside due to its Keytruda drug and pipeline, while Nvidia projects 28% growth despite recent market corrections; other pharma stocks show mixed outlooks.

Dow Jones Stocks Poised for Growth in 2025: Merck and Nvidia Lead the Way
Wall Street analysts predict strong gains for select Dow Jones stocks in 2025, with Merck leading at 32% projected upside due to its Keytruda drug and pipeline, while Nvidia projects 28% growth despite recent market corrections; other pharma stocks show mixed outlooks.
Progress
40% Bias Score
Showing 1 to 2 of 2 results